Nexus International posts $546M in H1 2025 revenue, driven by Brazil's regulated iGaming boom, rapid brand growth, and a ...

Bending Spoons, a serial acquirer of software businesses, has raised more than €500 million ($585 million) in debt to buy ...

Cross-training is not just for college athletes. It is also imperative for project managers looking to get ahead or for ...

The result marks the latest failure for a microbiome therapy in inflammatory bowel disease, which has long been a top target ...

Tennessee is punching above its weight in this year’s Inc. 5000 list of America’s fastest-growing private companies. A total ...

Beth Rodenhuis will return to the financial services company to serve as COO and business architect, overseeing the company's ...

The move by Mars marks a step toward appeasing Health and Human Services Secretary Robert F. Kennedy Jr, who has made ...

The Boston wearables firm says the software tool doesn't meet the definition of a medical device and shouldn't be regulated ...

In Texas, companies are scaling up and quickly growing their revenue. A new ranking of the 5,000 fastest-growing private ...

Eli Lilly has signed a deal worth $1.3 billion with privately held Superluminal Medicines to discover and develop small-molecule drugs through AI to treat obesity and other cardiometabolic diseases.

BioStem Technologies, Inc. (“BioStem” or the “Company”) (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for ...